SCHEMBL18960508

SCHEMBL18960508

Cc1cc(C)c(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)c(O)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 9/20 0.68
MAPK14 Q16539 14/20 0.65
MAPK13 O15264 13/20 0.65
MAPK12 P53778 13/20 0.65
MAPK11 Q15759 13/20 0.65
GCGR P47871 12/20 0.65
CSNK1D P48730 4/20 0.61
PRKD3 O94806 3/20 0.61
MAP4K4 O95819 3/20 0.61
FRK P42685 3/20 0.61
MAPK9 P45984 3/20 0.61
CSNK1A1 P48729 3/20 0.61
GSK3B P49841 3/20 0.61
CLK4 Q9HAZ1 3/20 0.61
PTK6 Q13882 2/20 0.61
CSNK1E P49674 2/20 0.61
PRKACA P17612 2/20 0.61
SLK Q9H2G2 2/20 0.61
KDM4E B2RXH2 1/20 0.61
CIT O14578 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5921871 0.92 MAPK14 (0.72) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL6960991 0.92 MAPK14 (0.72) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL5197068 0.83 MAPK14 (0.65) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL4553131 0.81 ALOX5 (1.00) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL17002222 0.81 MAPK14 (0.76) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL5184613 0.80 MAPK14 (0.64) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL5184500 0.80 MAPK14 (0.68) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL17002224 0.79 MAPK14 (0.67) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL2650684 0.79 MAPK11 (1.00) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL2650680 0.78 ALOX5 (0.77) ALOX5MAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170166867-A1 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170166867-A1 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS CSNK1A1, CSNK1G1, CSNK2A1 ALOX5 4450/4885MAPK14 241/4885MAPK13 234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.